CA
NZ
UK
AU
IND
US
Adaptive Biotechnologies (NASDAQ:ADPT), founded in 2009 and headquartered in Seattle, Washington, is a commercial-stage biotechnology company harnessing the biology of the adaptive immune system to transform disease diagnosis and treatment. The company operates through two core segments: Minimal Residual Disease Diagnostics, anchored by its …
Amgen (NASDAQ:AMGN) is a leading global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its extensive product portfolio spans oncology and hematology, inflammatory diseases, bone health, cardiovascular disease, nephrology, and neuroscience, …
AngioDynamics (NASDAQ:ANGO) is a medical technology company headquartered in Latham, New York, that designs, manufactures, and markets a broad range of minimally invasive, image-guided medical, surgical, and diagnostic devices used to treat peripheral vascular disease, support vascular access, and address oncology and surgical needs. …
BillionToOne (NASDAQ:BLLN) is a Menlo Park, California-based precision diagnostics company founded in 2016 by Dr. Oguzhan Atay and Dr. David Tsao, dedicated to making molecular diagnostics more powerful, efficient, and accessible. Its patented Quantitative Counting Templates platform is a proprietary molecular counting technology capable …
Dyne Therapeutics (NASDAQ:DYN) is a Waltham, Massachusetts-based clinical-stage biotechnology company focused on developing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Leveraging its proprietary FORCE platform, which delivers targeted oligonucleotide therapies directly to muscle tissue and the central nervous system, the company …
Elanco Animal Health (NYSE:ELAN) is a global animal health company headquartered in Greenfield and Indianapolis, Indiana, that innovates, develops, manufactures, and markets a broad portfolio of products for both companion animals and farm livestock. Its pet health offerings include parasiticides and vaccines like Seresto, …
Liquidia (NASDAQ:LQDA) is a Morrisville, North Carolina-based biopharmaceutical company focused on developing, manufacturing, and commercializing therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Its lead product, YUTREPIA, an inhaled dry powder formulation of treprostinil built …
The results highlight an important reality: companies building entirely new infrastructure rarely optimize for today's earnings. They optimize for tomorrow's capacity.
James M. Anderson, Chief Financial Officer of First Financial Bancorp /OH/, filed a statement of changes in beneficial ownership on August 5, 2026, reporting a transaction dated August 3, 2026, involving common stock of the Ohio-based banking company.
A Form 4 filed on August 5, 2026 discloses that John B. Hansen, a director of Mueller Industries Inc (NYSE: MLI), reported multiple transactions in the company's common stock dated August 4, 2026.
Please wait processing your request...